Biolase, Inc.
BIOL
BIOL was delisted on the 18th of June, 2024.
15 hedge funds and large institutions have $14.9M invested in Biolase, Inc. in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.
72% more capital invested
Capital invested by funds: $8.65M → $14.9M (+$6.21M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
17% less funds holding
Funds holding: 18 → 15 (-3)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TMC
Trellus Management Company
Delray Beach,
Florida
|
+$180K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$120K |
| 3 |
VF
Virtu Financial
New York
|
+$20K |
| 4 |
TFO
Tarbox Family Office
Newport Beach,
California
|
+$12K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Birchview Capital
Burlington,
Vermont
|
-$152K |
| 2 |
PCM
Princeton Capital Management
Red Bank,
New Jersey
|
-$48K |
| 3 |
GI
GAMCO Investors
Greenwich,
Connecticut
|
-$24K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$15K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$13K |
BIOL Hedge Fund Activity: Q3 2018 in Review
15 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q3 2018, worth a combined $14.9M — up 72% from $8.65M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of BIOL and 2 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 4 added.
The largest buyer was Trellus Management Company, opening a new position worth an estimated $180K. The largest seller was Birchview Capital, cutting an estimated $152K.
- 15 institutional investors held Biolase, Inc. (BIOL) as of Q3 2018, down from 18 in Q2 2018.
- Funds reported $14.9M of Biolase, Inc. stock for Q3 2018, up 72% quarter-over-quarter.
- 2 funds opened new Biolase, Inc. positions in Q3 2018 and 5 closed out, a net change of -3 holders.
- The largest Biolase, Inc. buyer in Q3 2018 was Trellus Management Company, an estimated $180K added.
- The largest Biolase, Inc. seller in Q3 2018 was Birchview Capital, an estimated $152K sold.
Based on aggregated 13F filings for Q3 2018.